![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, January 09, 2013 12:07:39 PM
Fresenius to open 30 dialysis clinics in India by 2015
PTI Dec 5, 2012, 06.28PM IST
http://articles.economictimes.indiatimes.com/2012-12-05/news/35620561_1_dialysis-clinics-new-delhi-robust-growth
Tags:
kidney therapy specialist|investments|India|Fresenius Medical Care India Managing Director|Fresenius Medical Care India (FMCI)|Fresenius Medical Care|Fresenius|Frank Wagner|dialysis clinics|Dhruv Chaturvedi|Dhruv|clinic business|Clinic
(Global kidney therapy specialist…)
NEW DELHI: Global kidney therapy specialist Fresenius Medical Care today it is embarking on an expansion drive in India, with plans to open up to 30 dialysis clinics across India by 2015.
The expansion will be undertaken by its wholly-owned subsidiary Fresenius Medical Care India (FMCI).
"FMCI will open up to 30 dialysis clinics across India at an investment of nearly Rs 60 crore," Fresenius Medical Care Executive Vice-President (Central Asia-Pacific) Frank Wagner told PTI.
The company is already marketing renal disease management products in India, he added.
"The clinics will be across India and apart from metro's the company is also looking at tier II and tier III cities," Fresenius Medical Care India Managing Director Dhruv Chaturvedi said.
The company is committed to India and if more investments are required it would be done, Wagner said.
"In India the price point is being kept between Rs 1,500- Rs 3,000 per session. Our aim is to give quality standards at affordable rates," he added.
The company also plans to open manufacturing facilities In India for some products as the volumes grow.
"We are looking to set up manufacturing facilities for some products," Wagner said.
Asia-Pacific market is growing at the fastest rate for the company and is witnessing a double digit growth. China, India, Korea and Taiwan will be the main drivers for growth in the region, he said.
At present the company has around 250 dialysis clinics in Asia, he added.
Fresenius Medical Care India had registered revenues of Rs 200 crore in the last year and has seen robust growth over the years.
"The company is witnessing growth of 25 to 30 per cent. With consolidation of products business and establishment of clinic business we expect it to be better," Chaturvedi said.
FEATURED ARTICLES
Recent AEMD News
- Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update • PR Newswire (US) • 06/27/2024 08:15:00 PM
- Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024 • PR Newswire (US) • 06/21/2024 12:01:00 PM
- Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial • PR Newswire (US) • 06/18/2024 12:01:00 PM
- Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies • PR Newswire (US) • 06/03/2024 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 05:24:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:05:28 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/17/2024 04:15:21 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/16/2024 08:05:23 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/15/2024 01:27:15 PM
- Aethlon Medical Announces Pricing of $4.7 Million Public Offering • PR Newswire (US) • 05/15/2024 01:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/13/2024 09:30:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 12:01:40 PM
- Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma • PR Newswire (US) • 05/10/2024 12:01:00 PM
- Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices • PR Newswire (US) • 02/21/2024 01:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 10:15:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:15:41 PM
- Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update • PR Newswire (US) • 02/14/2024 09:15:00 PM
- Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024 • PR Newswire (US) • 02/07/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:06:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:04:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:02:52 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:01:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 12:49:31 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM